sandoz-21-009 has been researched along with cgp 12177 in 1 studies
Studies (sandoz-21-009) | Trials (sandoz-21-009) | Recent Studies (post-2010) (sandoz-21-009) | Studies (cgp 12177) | Trials (cgp 12177) | Recent Studies (post-2010) (cgp 12177) |
---|---|---|---|---|---|
19 | 0 | 0 | 556 | 9 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akashi, H; Hosohata, Y; Kinami, J; Nagatomo, T; Sakuma, N; Tsuchihashi, H | 1 |
1 other study(ies) available for sandoz-21-009 and cgp 12177
Article | Year |
---|---|
Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Brain; Guinea Pigs; Heart Rate; In Vitro Techniques; Iodocyanopindolol; Kinetics; Muscle Contraction; Myocardium; Pindolol; Propanolamines; Radioligand Assay; Rats; Receptors, Adrenergic, beta; Trachea | 1991 |